HP and Brady Corp. are collaborating to provide one resource for product tracking and authentication. Brady Corp. is the first authorized reseller of the HP Global Product Authentication Service (HP GPAS), a cloud-based approach to identifying, locating, and fighting counterfeiting.
At this week's 7th Global Forum on Pharmaceutical AntiCounterfeiting & Diversion in Washington, DC, Robert Hormats, U.S. Under Secretary of State for Economic Affairs, detailed progress under the State Department’s Safe Medicines Strategy. The program includes U.S. funding of 24 projects mainly in Africa and Asia. For instance, a pilot project in India aimed at building awareness is reportedly reducing the use of fake medicines in certain villages.
TruTag Technologies today announced their participation in the Seventh Global Forum on Pharmaceutical AntiCounterfeiting and Diversion in Washington, DC, taking place November 27–29, 2012 at the Omni Shoreham Hotel. This East Coast conference is one of the largest global forums dedicated to the reduction and elimination of counterfeit and diverted medicine, and is held in proximity to an area with one of the greatest concentrations of pharmaceutical companies in the world.
Kodak will present at the Anti-Counterfeiting & Brand Protection Summit in the panel discussion, "Building Successful Criminal Cases to Combat Counterfeiting and Fraud.” The panel begins at 4:45 p.m. on Thursday, Sept. 20, at Sentry Centers in New York. Kevin Harrell, Kodak’s Director of Global Commercial Business for Security Solutions, will discuss how companies can use technology to forensically distinguish legitimate from counterfeit products and packaging and prevent diversion of goods within the supply chain, the company reported in a press release.
AlpVision and Nolato Medical announce a new partnership to establish collaborative activities to protect primary plastic packaging and medical devices against counterfeiting. The partnership builds on AlpVision's breakthrough patented Fingerprint(TM) technology, which enables brand owners in the pharmaceutical industry to track and authenticate mass produced products manufactured in a mold with a scanner or an iPhone.
California’s State Board of Pharmacy (CA BoP) met this week to begin preparing for implementation of the state’s electronic pedigree requirements. CA BoP hosted Connie T. Jung, FDA’s acting associate director for policy and communications in the Center for Drug Evaluation and Research, who explained FDA's goals for a track and trace system. While CA BoP nor FDA did not issue any new policies or make any new decisions, the meeting revealed how closely these two are working together.
This past week FDA participated in Operation Pangea IV, a coordinated international program to root out online sales of counterfeit and illegal medical products. The operation was this year's International Internet Week of Action (IIWA), which is coordinated by INTERPOL, the World Customs Organization, the Permanent Forum of International Pharmaceutical Crime, the Heads of Medicines Agencies Working Group of Enforcement Officers, and national health and law enforcement agencies from 81 participating countries.
By Marie Redding
Different suppliers are skilled in different areas, and pharma companies may sometimes benefit from their past experiences, often in other industries. One important part of an anti-counterfeit solution is choosing the right mix of covert and overt technologies, combined with the latest digital printing technologies.